Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis

Nature Genetics

Volumn 17, Issue 1, 1997, Pages 88-91

  Cormier, Robert T ^a   Hong, Karen H ^b,c   Halberg, Richard B ^a   Hawkins, Trevor L ^b   Richardson, Paul ^b   Mulherkar, Rita ^d   Dove, William F ^a   Lander, Eric S ^b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 4; FAMILIAL POLYPOSIS; GENE ASSIGNMENT; GENE LOCUS; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; DNA PRIMERS; GENES, APC; GENES, TUMOR SUPPRESSOR; GENOTYPE; HUMANS; IMMUNITY, NATURAL; INTESTINAL NEOPLASMS; MICE; MICE, INBRED AKR; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASES A; POLYMERASE CHAIN REACTION;

ANIMALIA; MAMMALIA;

EID: 0030797904     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0997-88     Document Type: Article

References (29)

1. Moser, A.R., Pilot, H.C. & Dove, W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 (1990).
2. Su, L-K. et al. A germline mutation of the murine homolog of the ARC gene causes multiple intestinal neoplasia. Science 256, 668-670 (1992).
3. Shoemaker, A.R., Gould, K.A., Luongo, C., Moser, A.R. & Dove, W.F. Studies of neoplasia in the Min mouse. Biochim. Biophys. Acta Rev. Cancer 1332, F25-F48 (1997).
4. Dietrich, W. et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631-639 (1993).
5. Gould, K.A. et al. Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice. Genetics 144, 1777-1785 (1996).
6. Min-induced intestinal neoplasia. Cell 81, 957-966 (1995).
7. Gould, K.A., Dietrich, W.F., Borenstein, N., Lander, E.S. & Dove, W.F. Mom 1 is a semi-dominant modifier of the size and multiplicity of intestinal adenomas in Min mice. Genetics 144, 1769-1776 (1996).
8. Gould, K.A. & Dove, W.F. Action of Min and Mom1 on neoplasia in ectopic intestinal grafts. Cell Growth Diff. 7, 1361-1368 (1996).
9. Gould K.A. & Dove, W.F. Localized action controlling intestinal neoplasia in mice. Proc. Natl. Acad. Sci. USA 94, 5848-5853 (1997).
10. 2 genes are linked and map to homologous chromosome regions in mouse and human. Genomics 32, 328-333 (1996).
11. Peelers, T. & Vantrappen, G. The paneth cell: a source of intestinal lysozyme. Gut 16, 553-558 (1975).
12. Rhodin, J.A.G. Histology: A Text and Atlas (Oxford University, New York, 1974).
13. æ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809 (1996).
14. 2 in activated mast cells. J. Biol. Chem. 272, 3231-3236 (1997).
15. 2. J. Clin. Invest 95, 603-610 (1995).
16. Min mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res. 57, 812-814 (1997).
17. Dudley, M.E., Sundberg, J.P. & Roopenian, D.C. Frequency and histological appearance of adenomas in multiple intestinal neoplasia mice are unaffected by severe combined immunodeficiency (scid) mice. Int J. Cancer 65, 249-253 (1996).
18. Tomlinson, I.P., Beck N.E., Neale, K. & Bodmer W.F. Variants at the secretory phospholipase A2 (PLA2G2a) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumors. Ann. Hum. Genet. 60, 369-376 (1996).
19. Spirio, L.N. et al. Three secretory phospholipase A2 genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. Cancer Res. 56, 955-958 (1996).
20. Lander, E.S. & Botstein, D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121, 185-199 (1989).
21. Hamilton, B.A. et al. The vibrator mutation causes neurodegeneration via reduced expression of PITPα: positional complementation cloning and extragenic suppression. Neuron 18, 711-722 (1997).
22. King, D.P. et al. Positional cloning of the mouse circadian clock gene. Cell 89, 641-653 (1997).
23. Dove, W.F. Molecular genetics of Mus musculus: point mutations and millimorgans. Genetics 116, 5-8 (1987).
24. Altshul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. Basic alignment search tool. Mol. Biol. 215, 403-410 (1996).
25. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989).
26. k. J. Mol. Biol. 228, 840-849 (1992).
27. Wagle, A., Desai, S. & Deo, M.G. Immunohistochemical localization of 'enhancing factor', a novel growth modulator in the mouse intestines. Cell Biol. Int. Rep. 13, 309-312 (1989).
28. Mulherkar, R. et al. Enhancing factor protein from mouse small intestines belongs to the phospholipase A2 family. FEBS Lett. 317, 263-266 (1993).
29. Mulherkar, R., Desai, S.J., Rao, R.S., Wagle, A.S. & Deo, M.G. Expression of enhancing factor gene and its localization in mouse tissues. Histochemistry 96, 367-370 (1991).